X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. Cyclobenzaprine
2. Flexeril
3. Lisseril
1. 6202-23-9
2. Cyclobenzaprine Hcl
3. Flexeril
4. Flexiban
5. Amrix
6. Lisseril
7. 3-(5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethylpropan-1-amine Hydrochloride
8. Cyclobenzaprine (hydrochloride)
9. Mk 130 Hydrochloride
10. Proheptatriene Hydrochloride
11. Mk130 Hydrochloride
12. Proheptatriene Monohydrochloride
13. Tnx-102
14. Nsc-78206
15. Nsc-169900
16. Nsc-173379
17. 0ve05jys2p
18. Chebi:3997
19. 5-(3-dimethylaminopropylidene)dibenzo[a,e]cycloheptatriene Hydrochloride
20. 1-propanamine, 3-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-n,n-dimethyl-, Hydrochloride
21. N,n-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride
22. Cycloflex
23. Tensodox
24. Cloben
25. Cyben
26. Novo-cycloprine
27. Flexeril Hydrochloride
28. Dsstox_cid_25105
29. Dsstox_rid_80672
30. Dsstox_gsid_45105
31. Tabradol
32. Yurelax
33. Miosan
34. Mk-130 Hcl
35. Multi-relax
36. 10,11.delta.-amitriptyline Hydrochloride
37. Proheptatrien Monohydrochloride
38. Wln: L C676 Bhj B3n1&1 &gh
39. Nsc78206
40. 5h-dibenzo[a, N,n-dimethyl-, Hydrochloride
41. Nsc169900
42. Nsc173379
43. Sr-01000075761
44. Cyclobenzaprine Hydrochloride [usan]
45. Einecs 228-264-4
46. Cas-6202-23-9
47. Nsc 78206
48. Unii-0ve05jys2p
49. Nsc 169900
50. Nsc 173379
51. 10,11delta-amitriptyline Hydrochloride
52. 5h-dibenzo[a,.gamma.-propylamine, N,n-dimethyl-, Hydrochloride
53. N,d]cycloheptene-.delta.,5.gamma.-propylamine, Hydrochloride
54. Tonmya
55. 1-propanamine,d]cyclohepten-5-ylidene)-n,n-dimethyl-, Hydrochloride
56. N,d]cycloheptene-.delta.(sup5,.gamma.)-propylamine Hydrochloride
57. 5-[3-(dimethylamino)propylidene]-5h-dibenzo-[a,d]cycloheptene Hydrochloride
58. 3-(dibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-n,n-dimethylpropan-1-amine;hydrochloride
59. Flexeril (tn)
60. Prestwick_790
61. Mfcd00079039
62. Cyclobenzaprine Hydrochloride [usan:usp]
63. Nortriptyline Impurity E
64. 5-(3-dimethylaminopropylidene)-5h-dibenzo-(a,d)cycloheptene Hydrochloride
65. N,n-dimethyl-5h-dibenzo(a,d)cycloheptene-delta(sup 5,gamma)-propylamine Hydrochloride
66. Schembl41376
67. Mls002153815
68. Mk-130 Hydrochloride
69. Spectrum1503207
70. Amy502
71. Tnx-102 Sl
72. Chembl1200636
73. Dtxsid2045105
74. Tnx-105
75. Hms1569i12
76. Hms1922i11
77. Pharmakon1600-01503207
78. Act06294
79. Bcp21781
80. Cyclobenzaprine Hydrochloride (usp)
81. Eur-1002
82. Hy-b0740
83. Tox21_110040
84. Tox21_500303
85. Ccg-39312
86. Nsc758414
87. S4283
88. 3-(5h-dibenzo(a,d)cyclohepten-5-ylidene)propyl(dimethyl)ammonium Chloride
89. Akos015906329
90. Tox21_110040_1
91. Ac-1916
92. Bcp9000565
93. Lp00303
94. Nsc-758414
95. Sb19022
96. 5h-dibenzo(a,d)cycloheptene-delta(sup 5)-gamma-propylamine, N,n-dimethyl-, Hydrochloride
97. 5h-dibenzo(a,d)cycloheptene-delta5,gamma-propylamine, N,n-dimethyl-, Hydrochloride
98. Ncgc00013841-01
99. Ncgc00013841-09
100. Ncgc00093752-01
101. Ncgc00093752-02
102. Ncgc00093752-03
103. Ncgc00093752-04
104. Ncgc00093752-05
105. Ncgc00095017-01
106. Ncgc00095017-02
107. Ncgc00095017-03
108. Ncgc00095017-04
109. Ncgc00260988-01
110. As-15745
111. Bc181325
112. Cyclobenzaprine Hydrochloride [mi]
113. Smr000326702
114. Cyclobenzaprine Hydrochloride [mart.]
115. Cyclobenzaprine Hydrochloride [vandf]
116. Eu-0100303
117. Ft-0603166
118. Sw196928-3
119. Cyclobenzaprine Hydrochloride [usp-rs]
120. Cyclobenzaprine Hydrochloride [who-dd]
121. A14255
122. C 4542
123. D00772
124. L10029
125. 202c239
126. A854881
127. Cyclobenzaprine Hydrochloride [orange Book]
128. Cyclobenzaprine Hydrochloride [usp Impurity]
129. Cyclobenzaprine Hydrochloride [usp Monograph]
130. Sr-01000075761-1
131. Sr-01000075761-6
132. W-105056
133. Q27106282
134. Cyclobenzaprine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
135. 3-(5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethylpropan-1-aminehydrochloride
136. 3-(5h-dibenzo[a,d]cyclohepten-5-ylidene)-n,n-dimethylpropan-1-amine Hydrochloride
137. Cyclobenzaprine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
138. N,n-dimethyl-5h-dibenzo(a,d)cycloheptene-delta(5,gamma)-propylamine Hydrochloride
139. 3-(5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethylpropan-1-amine Hydrochloride (cyclobenzaprine Hydrochloride)
140. Cyclobenzaprine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
141. N,n-dimethyl-5h-dibenzo(a,d)cycloheptene-(sup .delta.5,.gamma.)-propylamine Hydrochloride
| Molecular Weight | 311.8 g/mol |
|---|---|
| Molecular Formula | C20H22ClN |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 3 |
| Exact Mass | 311.1440774 g/mol |
| Monoisotopic Mass | 311.1440774 g/mol |
| Topological Polar Surface Area | 3.2 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 365 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Amrix |
| PubMed Health | Cyclobenzaprine (By mouth) |
| Drug Classes | Skeletal Muscle Relaxant, Centrally Acting |
| Drug Label | AMRIX (Cyclobenzaprine Hydrochloride Extended-Release Capsules) is a skeletal muscle relaxant which relieves muscle spasm of local origin without interfering with muscle function. The active ingredient in AMRIX extended-release capsules is cycloben... |
| Active Ingredient | Cyclobenzaprine hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 30mg; 15mg |
| Market Status | Prescription |
| Company | Ivax Intl |
| 2 of 4 | |
|---|---|
| Drug Name | Cyclobenzaprine hydrochloride |
| Drug Label | Cyclobenzaprine hydrochloride is a white, crystalline tricyclic amine salt. It has a melting point of 217C, and a pKa of 8.47 at 25C. It is freely soluble in water and alcohol, sparingly soluble in isopropanol, and insoluble in hydrocarbon solven... |
| Active Ingredient | Cyclobenzaprine hydrochloride |
| Dosage Form | Tablet; Capsule, extended release |
| Route | oral; Oral |
| Strength | 5mg; 7.5mg; 30mg; 10mg; 15mg |
| Market Status | Tentative Approval; Prescription |
| Company | Vintage Pharms; Twi Pharms; Ranbaxy; Mylan Pharms; Jubilant Cadista; Mutual Pharm; Kvk Tech; Actavis Labs Fl; Orit Labs; Aurobindo Pharma; Prosam Labs; Pliva; Invagen Pharms; Par Pharm |
| 3 of 4 | |
|---|---|
| Drug Name | Amrix |
| PubMed Health | Cyclobenzaprine (By mouth) |
| Drug Classes | Skeletal Muscle Relaxant, Centrally Acting |
| Drug Label | AMRIX (Cyclobenzaprine Hydrochloride Extended-Release Capsules) is a skeletal muscle relaxant which relieves muscle spasm of local origin without interfering with muscle function. The active ingredient in AMRIX extended-release capsules is cycloben... |
| Active Ingredient | Cyclobenzaprine hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 30mg; 15mg |
| Market Status | Prescription |
| Company | Ivax Intl |
| 4 of 4 | |
|---|---|
| Drug Name | Cyclobenzaprine hydrochloride |
| Drug Label | Cyclobenzaprine hydrochloride is a white, crystalline tricyclic amine salt. It has a melting point of 217C, and a pKa of 8.47 at 25C. It is freely soluble in water and alcohol, sparingly soluble in isopropanol, and insoluble in hydrocarbon solven... |
| Active Ingredient | Cyclobenzaprine hydrochloride |
| Dosage Form | Tablet; Capsule, extended release |
| Route | oral; Oral |
| Strength | 5mg; 7.5mg; 30mg; 10mg; 15mg |
| Market Status | Tentative Approval; Prescription |
| Company | Vintage Pharms; Twi Pharms; Ranbaxy; Mylan Pharms; Jubilant Cadista; Mutual Pharm; Kvk Tech; Actavis Labs Fl; Orit Labs; Aurobindo Pharma; Prosam Labs; Pliva; Invagen Pharms; Par Pharm |
Antidepressive Agents, Tricyclic
Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
Tranquilizing Agents
A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. (See all compounds classified as Tranquilizing Agents.)
Market Place
